The Interconnected Issue
Like it or not, we’re all connected. While officials debate whether to strengthen treaties or build walls, infectious diseases easily cross every border. This issue of Spotlight includes a story about how genetics help us understand the way HIV moves within a community, a story about how migrants may influence HIV prevention efforts, and another on how budget cuts could imperil our response to the next pandemic. Plus a profile of the new BHP Lab Director. Continue reading
Major HIV prevention trials are underway in African countries, including Botswana, Kenya, South Africa, Uganda, and Zambia. These trials involve hundreds of thousands of people and cost hundreds of millions of dollars. But how will we know if they work?
When “Treatment as Prevention” was named Science magazine’s Breakthrough of the Year in 2011, there was optimism that we were closing in on AIDS. Results published from the HPTN 052 trial that year showed that in discordant couples, giving antiretroviral treatment (ART) to people with HIV not only was good for their own health, but also lowered the levels of HIV in their blood to undetectable levels, making the chance of infecting their partners extremely unlikely. Continue reading
If a boy from a Botswana village wins second place in the national science fair for a project on optimizing alcoholic brews, predictions about his future could involve his getting into trouble, or working for a large beer company, or, if you’re Dr. Simani Gaseitsiwe, becoming the director of one of Africa’s top research labs. Continue reading
President Donald Trump’s proposed budget calls for eliminating the Fogarty International Center at the National Institutes of Health (NIH). Last year, just $69 million of the NIH’s $31 billion budget was allocated to Fogarty.
Founded in 1968, the Fogarty Center serves as a bridge between the NIH and the greater global health community by facilitating exchanges among investigators, providing training opportunities, and supporting promising research initiatives in developing countries. Continue reading
The untold story of how Max Essex, some cat ladies, and a small team of researchers saved the lives of millions of felines—and helped identify the cause of AIDS.
By Genevieve Rajewski
In the 1970s, a little-understood virus was the number one killer of cats in the United States. So little was known about it that, in 1970, when an elderly woman first started bringing cats sick with cancer to Angell Memorial Hospital in Boston—the original veterinary teaching hospital for Tufts—there was next to nothing that her veterinarian, Susan Cotter, could do. Read the complete story in TuftsNow.
Illustration by James Steinberg
As our colleagues at the Botswana Harvard AIDS Institute Partnership conclude their 20th anniversary celebrations, we at HAI would like to express our appreciation for the professional collaborations and personal friendships shared for over two decades.
From left: Tun-Hou Lee, Max Essex, Phyllis Kanki, William Haseltine, Mark Wainberg
Researchers at the Harvard AIDS Initiative (HAI) were saddened to learn that their much-loved colleague Mark Wainberg met his death while swimming in strong surf off Bal Harbour, Florida, on Tuesday, April 11th.
“Mark was an outstanding scientist, a dedicated humanitarian, and a great friend. He had tremendous commitment to solving the HIV/AIDS epidemic,” said Max Essex, Chair of HAI, who knew Wainberg for over 40 years.
The heart of Botswana Harvard AIDS Institute Partnership (BHP) operations is the busy, three-story building on the grounds of Princess Marina, the main public hospital in Gaborone. The crowded research building houses the Botswana- Harvard HIV Reference Laboratory, the Data Management Centre, and office space for BHP staff. Continue reading
Lives saved are always cause for celebration. The morning of January 26, 2017, in a hotel meeting room in Gaborone, Botswana, AIDS researchers, government officials, and others came together to celebrate 20 years of research, education, and training efforts by the Botswana Harvard AIDS Institute Partnership (BHP) to end the AIDS epidemic in southern Africa. Continue reading